Technical Analysis for FBIO - Fortress Biotech, Inc.

Grade Last Price % Change Price Change
grade C 1.67 -7.73% -0.14
FBIO closed down 7.73 percent on Thursday, September 19, 2019, on 68 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical FBIO trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -7.73%
Bollinger Band Squeeze Range Contraction -7.73%
MACD Bearish Signal Line Cross Bearish -10.22%
Bollinger Band Squeeze Range Contraction -10.22%
Inside Day Range Contraction -10.22%

Older signals for FBIO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Fortress Biotech, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. The company's principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201, a biologic comprising the microscopic eggs of the porcine whipworm for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis, or autism spectrum disorder; and CNDO-109, a biologic that activates the immune system's natural killer cells to seek and destroy cancer cells for the treatment of acute myeloid leukemia. It has strategic alliances and commercial agreements with Ovamed GmbHp; Dr. Falk Pharma GmbH; and Freie Universität Berlin. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was founded in 2006 and is based in Burlington, Massachusetts.
Medicine Biotechnology Biopharmaceutical Cancer Medical Specialties Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Acute Myeloid Leukemia Ulcerative Colitis Abdominal Pain Crohn's Disease Treatment Of Acute Myeloid Leukemia Treatment Of Autoimmune Diseases
Is FBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.59
52 Week Low 0.49
Average Volume 350,131
200-Day Moving Average 1.6162
50-Day Moving Average 1.5808
20-Day Moving Average 1.8115
10-Day Moving Average 1.867
Average True Range 0.1332
ADX 33.17
+DI 21.869
-DI 16.3789
Chandelier Exit (Long, 3 ATRs ) 1.6504
Chandelier Exit (Short, 3 ATRs ) 1.9746
Upper Bollinger Band 1.9921
Lower Bollinger Band 1.6309
Percent B (%b) 0.11
BandWidth 19.939277
MACD Line 0.0609
MACD Signal Line 0.0855
MACD Histogram -0.0246
Fundamentals Value
Market Cap 84.38 Million
Num Shares 50.5 Million
EPS -1.48
Price-to-Earnings (P/E) Ratio -1.13
Price-to-Sales 1.68
Price-to-Book 2.53
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.93
Resistance 3 (R3) 1.95 1.90 1.88
Resistance 2 (R2) 1.90 1.83 1.88 1.87
Resistance 1 (R1) 1.78 1.79 1.76 1.76 1.85
Pivot Point 1.73 1.73 1.71 1.71 1.73
Support 1 (S1) 1.61 1.66 1.59 1.59 1.49
Support 2 (S2) 1.56 1.62 1.54 1.47
Support 3 (S3) 1.44 1.56 1.46
Support 4 (S4) 1.42